JPMorgan Chase & Co. Increases SpringWorks Therapeutics (NASDAQ:SWTX) Price Target to $74.00
SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) had its price target hoisted by investment analysts at JPMorgan Chase & Co. from $73.00 to $74.00 in a note issued to investors on Wednesday, Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside […]
More Stories
MercadoLibre, Inc. (NASDAQ:MELI) Shares Acquired by PFG Investments LLC
PFG Investments LLC lifted its stake in shares of MercadoLibre, Inc. (NASDAQ:MELI – Free Report) by 9.4% during the first...
11,607 Shares in Otis Worldwide Corporation (NYSE:OTIS) Purchased by Kentucky Retirement Systems Insurance Trust Fund
Kentucky Retirement Systems Insurance Trust Fund purchased a new position in shares of Otis Worldwide Corporation (NYSE:OTIS – Free Report)...
Kentucky Retirement Systems Insurance Trust Fund Lowers Stock Position in Consolidated Edison Inc (NYSE:ED)
Kentucky Retirement Systems Insurance Trust Fund trimmed its holdings in shares of Consolidated Edison Inc (NYSE:ED – Free Report) by...
Latest USA Tariff Developments: Impact on Global Economy & Trade
After taking on the White House for his second tenure, US President Donald Trump has announced a series of tariffs....
Exxon Mobil Corporation (NYSE:XOM) Shares Sold by Guyasuta Investment Advisors Inc.
Guyasuta Investment Advisors Inc. cut its holdings in Exxon Mobil Corporation (NYSE:XOM – Free Report) by 1.2% during the first...
Linde PLC (NASDAQ:LIN) Shares Sold by PFG Investments LLC
PFG Investments LLC cut its holdings in shares of Linde PLC (NASDAQ:LIN – Free Report) by 7.9% during the first...